Form 4: Colgate-Palmolive CEO Noel Wallace Reports Stock Transactions

Colgate-Palmolive CEO Noel Wallace reports acquisition of restricted stock units and stock options, as well as the disposal of shares to cover tax liabilities.

Summary

• On September 12, 2024, Noel R. Wallace, Chairman, President & CEO of Colgate-Palmolive, was granted 20,689 restricted stock units.
• These restricted stock units vest in equal 1/3 installments on each of the first, second, and third anniversary of the grant date.
• Also on September 12, 2024, Wallace was granted a stock option to buy 145,696 shares of Colgate-Palmolive common stock at an exercise price of $106.34.
• The stock option becomes exercisable in equal annual installments over three years, starting on the first anniversary of the grant date.
• On September 13, 2024, Wallace disposed of 4,039 shares at a price of $105.73 to cover tax liabilities related to the vesting of restricted stock units.
• Following these transactions, Wallace directly owns 303,809 shares of Colgate-Palmolive common stock.
• Wallace also indirectly owns 52,320 shares through the Issuer's 401(k) Plan Trustee, 52,000 shares through a Spouse Trust, and 335 shares through another trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock options and restricted stock units suggests confidence in the company's future performance. The disposal of shares for tax purposes is a routine transaction and doesn't significantly impact the overall sentiment.

Positives

• The grant of restricted stock units and stock options aligns the CEO's interests with those of the shareholders, incentivizing long-term performance.
• The vesting schedule of the restricted stock units and stock options encourages continued service and commitment from the CEO.

Negatives

• The disposal of shares to cover tax liabilities, while a common practice, slightly reduces the CEO's direct holdings in the company.

Industry Context

Executive compensation packages often include stock options and restricted stock units to align management's interests with shareholder value. These grants are standard practice among publicly traded companies like Colgate-Palmolive to incentivize performance and retain key executives.

Comparison to Industry Standards

• Colgate-Palmolive's executive compensation practices, including the use of stock options and restricted stock units, are consistent with industry standards among large, publicly traded consumer goods companies.
• Companies like Procter & Gamble (P&G) and Unilever also utilize similar equity-based compensation strategies to incentivize their top executives.
• The vesting schedules and exercise prices are typical for such grants, designed to reward long-term value creation.

Stakeholder Impact

• Shareholders may view the equity grants positively, as they align management's interests with the company's long-term success.
• Employees may see the grants as a sign of the company's commitment to its leadership.

Key Dates